The proapoptotic Bcl-2 family member bim plays a central role during the development of virus-induced hepatitis

Journal of Immunology

Volumn 188, Issue 2, 2012, Pages 916-922

  Lauer, Christoph ^a   Brunner, Thomas ^b   Corazza, Nadia ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CASPASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL TYPE; CELLULAR IMMUNITY; CHEMOSENSITIVITY; CHIMERA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; LIVER CELL; LIVER INJURY; LIVER PROTECTION; LYMPHATIC SYSTEM; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYMPHOID COMPARTMENT; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL CLEARANCE; VIRUS HEPATITIS;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIGENE FAMILY; PROTO-ONCOGENE PROTEINS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS;

EID: 84855989834     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101864     Document Type: Article

References (33)

1. Guidotti, L. G., and F. V. Chisari. 2006. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 1: 23-61.
2. Nakamoto, Y., L. G. Guidotti, V. Pasquetto, R. D. Schreiber, and F. V. Chisari. 1997. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158: 5692-5697. (Pubitemid 127483973)
3. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3: 409-413. (Pubitemid 27145682)
4. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158: 5283-5291. (Pubitemid 127681233)
5. Gremion, C., B. Grabscheid, B. Wölk, D. Moradpour, J. Reichen, W. Pichler, and A. Cerny. 2004. Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction. J. Virol. 78: 2152-2157. (Pubitemid 38176748)
6. Zinkernagel, R. M., E. Haenseler, T. Leist, A. Cerny, H. Hengartner, and A. Althage. 1986. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virusspecific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J. Exp. Med. 164: 1075-1092. (Pubitemid 16031607)
7. Balkow, S., A. Kersten, T. T. Tran, T. Stehle, P. Grosse, C. Museteanu, O. Utermöhlen, H. Pircher, F. vonWeizsäcker, R. Wallich, et al. 2001. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J. Virol. 75: 8781-8791. (Pubitemid 32768982)
8. Bergthaler, A., D. Merkler, E. Horvath, L. Bestmann, and D. D. Pinschewer. 2007. Contributions of the lymphocytic choriomeningitis virus glycoprotein and polymerase to strain-specific differences in murine liver pathogenicity. J. Gen. Virol. 88: 592-603. (Pubitemid 46210899)
9. Kägi, D., B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232. (Pubitemid 26130183)
10. Kägi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25: 3256-3262.
11. O'Connor, L., A. Strasser, L. A. O'Reilly, G. Hausmann, J. M. Adams, S. Cory, and D. C. Huang. 1998. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17: 384-395. (Pubitemid 28045479)
12. Hsu, S. Y., P. Lin, and A. J. Hsueh. 1998. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members. Mol. Endocrinol. 12: 1432-1440. (Pubitemid 128496203)
13. Weant, A. E., R. D. Michalek, I. U. Khan, B. C. Holbrook, M. C. Willingham, and J. M. Grayson. 2008. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28: 218-230. (Pubitemid 351215232)
14. Pellegrini, M., G. Belz, P. Bouillet, and A. Strasser. 2003. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc. Natl. Acad. Sci. USA 100: 14175-14180. (Pubitemid 37499210)
15. Hughes, P. D., G. T. Belz, K. A. Fortner, R. C. Budd, A. Strasser, and P. Bouillet. 2008. Apoptosis regulators Fas and Bim cooperate in shutdown of chronic immune responses and prevention of autoimmunity. Immunity 28: 197-205. (Pubitemid 351215234)
16. Grayson, J. M., A. E. Weant, B. C. Holbrook, and D. Hildeman. 2006. Role of Bim in regulating CD8+ T-cell responses during chronic viral infection. J. Virol. 80: 8627-8638. (Pubitemid 44384873)
17. Corazza, N., S. Jakob, C. Schaer, S. Frese, A. Keogh, D. Stroka, D. Kassahn, R. Torgler, C. Mueller, P. Schneider, and T. Brunner. 2006. TRAIL receptormediated JNK activation and Bim phosphorylation critically regulate Fasmediated liver damage and lethality. J. Clin. Invest. 116: 2493-2499. (Pubitemid 44330148)
18. Kaufmann, T., P. J. Jost, M. Pellegrini, H. Puthalakath, R. Gugasyan, S. Gerondakis, E. Cretney, M. J. Smyth, J. Silke, R. Hakem, et al. 2009. Fatal hepatitis mediated by tumor necrosis factor TNFalpha requires caspase-8 and involves the BH3-only proteins Bid and Bim. Immunity 30: 56-66.
19. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Köntgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738. (Pubitemid 129515880)
20. Bouillet, P., J. F. Purton, D. I. Godfrey, L.-C. Zhang, L. Coultas, H. Puthalakath, M. Pellegrini, S. Cory, J. M. Adams, and A. Strasser. 2002. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926. (Pubitemid 34174755)
21. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17: 1675-1687. (Pubitemid 28119121)
22. Kaufmann, T., L. Tai, P. G. Ekert, D. C. Huang, F. Norris, R. K. Lindemann, R. W. Johnstone, V. M. Dixit, and A. Strasser. 2007. The BH3-only protein bid is dispensable for DNA damage-and replicative stress-induced apoptosis or cellcycle arrest. Cell 129: 423-433. (Pubitemid 46574974)
23. Yin, X. M., K. Wang, A. Gross, Y. Zhao, S. Zinkel, B. Klocke, K. A. Roth, and S. J. Korsmeyer. 1999. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886-891. (Pubitemid 29406726)
24. Badmann, A., A. Keough, T. Kaufmann, P. Bouillet, T. Brunner, and N. Corazza. 2011. Role of TRAIL and the pro-apoptotic Bcl-2 homolog Bim in acetaminophen- induced liver damage. Cell Death Dis. 2: e171.
25. Schneider-Jakob, S., N. Corazza, A. Badmann, D. Sidler, R. Stuber-Roos, A. Keogh, S. Frese, M. Tschan, and T. Brunner. 2010. Synergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and Bid. Cell Death Dis. 1: e86.
26. Malhi, H., S. F. Bronk, N. W. Werneburg, and G. J. Gores. 2006. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 281: 12093-12101. (Pubitemid 43855473)
27. Battegay, M., S. Cooper, A. Althage, J. Bänziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33: 191-198.
28. Wonderlich, J., G. Shearer, A. Livingstone, and A. Brooks. 2006. Induction and measurement of cytotoxic T lymphocyte activity. Curr. Protoc. Immunol. Chapter 3: Unit 3.11.
29. Lang, P. A., C. Contaldo, P. Georgiev, A. M. El-Badry, M. Recher, M. Kurrer, L. Cervantes-Barragan, B. Ludewig, T. Calzascia, B. Bolinger, et al. 2008. Aggravation of viral hepatitis by platelet-derived serotonin. Nat. Med. 14: 756-761. (Pubitemid 351951519)
30. Ludwinski, M. W., J. Sun, B. Hilliard, S. Gong, F. Xue, R. J. Carmody, J. DeVirgiliis, and Y. H. Chen. 2009. Critical roles of Bim in T cell activation and T cell-mediated autoimmune inflammation in mice. J. Clin. Invest. 119: 1706-1713.
31. Roth, E., and H. Pircher. 2004. IFN-gamma promotes Fas ligand- and perforinmediated liver cell destruction by cytotoxic CD8 T cells. J. Immunol. 172: 1588-1594. (Pubitemid 38116805)
32. Kennedy, N. J., J. Q. Russell, N. Michail, and R. C. Budd. 2001. Liver damage by infiltrating CD8+ T cells is Fas dependent. J. Immunol. 167: 6654-6662. (Pubitemid 33081604)
33. Martin, P., J. Pardo, N. Schill, L. Jöckel, M. Berg, C. J. Froelich, R. Wallich, and M. M. Simon. 2010. Granzyme B-induced and caspase 3-dependent cleavage of gelsolin by mouse cytotoxic T cells modifies cytoskeleton dynamics. J. Biol. Chem. 285: 18918-18927.